Trial record 1 of 1 for:    NCT01244191
Previous Study | Return to List | Next Study

ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Daiichi Sankyo Development Limited
ArQule
Information provided by (Responsible Party):
Daiichi Sankyo Inc.
ClinicalTrials.gov Identifier:
NCT01244191
First received: November 17, 2010
Last updated: September 30, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2014
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
No publications provided by Daiichi Sankyo Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):